Use of flunisolide to treat respiratory diseases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/193

A61K 31/56 (2006.01)

Patent

CA 1083963

USE OF FLUNISOLIDE TO TREAT RESPIRATORY DISEASES Abstract of The Disclosure Flunisolide, 6.alpha.-fluoro-11.beta.,21-dihydroxy-16.alpha.,17.alpha.-isopropyli- denedioxypregna-1,4-diene-3,20-dione, is administered by inhala- tion in a therapeutically effective dosage to a person having a respiratory disease such as bronchial asthma and allergic rhinitis. A unique crystalline polymorphic form of flunisolide is prepared by contacting one of the other polymorphic forms o solid flunisolide with a suitable liquid in which flunisolide has substantially no solubility, especially Freon? 12 or Freon? 114 or by recrystallizlng the unique crystalline form from a suitable solvent such as methylene chloride. The unique crystalline form is stable in aerosols such as Freon? mixtures and is valuable in the treatment of respiratory diseases.

332220

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of flunisolide to treat respiratory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of flunisolide to treat respiratory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of flunisolide to treat respiratory diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1152455

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.